Magnesium Sulfate Heptahydrate Kalceks

Magnesium sulfate heptahydrate, the active ingredient in Magnesium Sulfate Heptahydrate Kalceks, is a mineral salt presented as a sterile injectable solution for intramuscular and intravenous use. It is employed to prevent and treat eclampsia and severe preeclampsia, to correct magnesium deficiency, and to manage torsades de pointes cardiac arrhythmia.

GNH USA supplies Magnesium Sulfate Heptahydrate Kalceks as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Magnesium sulfate heptahydrate acts on electrolyte balance and neuromuscular transmission, making it useful in several clinical settings. - Eclampsia and severe preeclampsia: prevents seizures and stabilises maternal blood pressure in pregnant women. - Magnesium deficiency: restores normal serum magnesium levels and supports neuromuscular function. - Torsades de pointes: terminates ventricular tachyarrhythmia by stabilising cardiac electrical activity.

Magnesium sulfate may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Flushing or feeling of warmth - Nausea or vomiting - Headache - Mild hypotension

Serious or Rare Side Effects: - Respiratory depression or arrest - Severe hypotension or cardiovascular collapse - Hypermagnesemia leading to cardiac arrhythmia - Anaphylactic or severe allergic reactions

Use magnesium sulfate with careful clinical monitoring and appropriate patient selection. - Serum magnesium monitoring: check levels before and during therapy to avoid toxicity. - Renal function assessment: adjust dosing in patients with impaired renal clearance. - Cardiac conduction disorders: use cautiously in patients with heart block or bradyarrhythmias. - Infusion rate: avoid rapid intravenous administration to reduce risk of hypotension. - Storage: Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Magnesium sulfate can interact with several drug classes, requiring attention to dosing and monitoring.

Major Interactions (Avoid): - Neuromuscular blocking agents: potentiates muscle relaxation and may cause prolonged paralysis. - Calcium channel blockers: additive vasodilatory effect can lead to severe hypotension. - Other magnesium‑containing products: risk of hypermagnesemia.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: may enhance renal effects of magnesium. - Loop or thiazide diuretics: can alter magnesium balance, requiring serum level checks.